The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Enovis Corporation (NYSE:ENOV) is one of the top small cap stocks with huge growth potential. On May 19, Enovis Corporation (NYSE:ENOV) disclosed in an SEC filing that its shareholders approved five proposals, among them being an amendment to the company’s 2020 Omnibus Incentive Plan.

egyjanek/Shutterstock.com

The amendment expands the pool of shares available for employee equity awards and significantly raises the compensation ceiling for independent board directors. It authorized an additional 3,650,000 shares of common stock for issuance under the 2020 plan. The amendment also raises the annual compensation cap for each independent director from $350,000 to $750,000. An exception allows the cap to reach up to 200% of the new $750,000 limit.

Separately, on May 7, Enovis reported its Q1 2026 financial results and said that it earned $589.2 million in revenue. The figure was 5.4% higher than in Q1 2025 and surpassed the $573 million analyst consensus. Non-GAAP adjusted EPS was $0.89 compared to $0.81 that Wall Street expected.

Ben Berry, Enovis CFO, told investors on the earnings call that the company revised its non-GAAP definitions following an SEC comment letter process. They removed the historical adjustment for inventory step-up charges related to the Lima acquisition.

Management maintained its outlook for revenue of $2.31-$2.37 billion, adjusted EBITDA of $425-$435 million, adjusted EPS of $3.52-$3.73, and free cash flow conversion above 25%.

Enovis Corporation (NYSE:ENOV) is a medical technology company. It develops orthopedic and rehabilitation products, including surgical implants, braces, recovery systems, and digital healthcare solutions. The company serves healthcare providers and patients through its Reconstruction and Prevention & Recovery segments.

While we acknowledge the potential of ENOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks and Top 10 Stocks to Buy for Long Term.

Disclosure: None. Follow Insider Monkey on Google News.